{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T16:15:02Z","timestamp":1783181702799,"version":"3.54.6"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S10OD034259"],"award-info":[{"award-number":["S10OD034259"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bioorg.2026.109970","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T23:59:08Z","timestamp":1778284748000},"page":"109970","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The design, synthesis and evaluation of the first carbon-11 positron emission tomography radiotracer for ASK1 imaging"],"prefix":"10.1016","volume":"178","author":[{"given":"Yafei","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongle","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.109970_bb0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jbior.2017.10.002","article-title":"Structural aspects of protein kinase ASK1 regulation","volume":"66","author":"Obsil","year":"2017","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.bioorg.2026.109970_bb0010","first-page":"1","article-title":"Pathophysiological roles of ASK1-MAP kinase signaling pathways","volume":"40","author":"Nagai","year":"2007","journal-title":"J. Biochem. Mol. Biol."},{"key":"10.1016\/j.bioorg.2026.109970_bb0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1247\/csf.28.23","article-title":"Roles of MAPKKK ASK1 in stress-induced cell death","volume":"28","author":"Takeda","year":"2003","journal-title":"Cell Struct. Funct."},{"key":"10.1016\/j.bioorg.2026.109970_bb0020","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.bbagen.2007.12.011","article-title":"Redox control of cell fate by MAP kinase: physiological roles of ASK1-MAP kinase pathway in stress signaling","volume":"1780","author":"Matsuzawa","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bioorg.2026.109970_bb0025","article-title":"Therapeutic potential of ASK1 activators in cancer treatment: current insights and future directions","volume":"178","author":"Wang","year":"2024","journal-title":"Biomed. Pharmacother. Biomedecine Pharmacother."},{"key":"10.1016\/j.bioorg.2026.109970_bb0030","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1517\/14728220902980249","article-title":"Targeting ASK1 in ER stress-related neurodegenerative diseases","volume":"13","author":"Homma","year":"2009","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bioorg.2026.109970_bb0035","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.3390\/ijms15022119","article-title":"Apoptosis signal regulating kinase 1 (ASK1): potential as a therapeutic target for Alzheimer's disease","volume":"15","author":"Song","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.109970_bb0040","doi-asserted-by":"crossref","first-page":"13395","DOI":"10.3390\/ijms222413395","article-title":"Structural insights support targeting ASK1 kinase for therapeutic interventions","volume":"22","author":"Obsilova","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.109970_bb0045","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jbior.2017.08.003","article-title":"ASK1 in neurodegeneration","volume":"66","author":"Guo","year":"2017","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.bioorg.2026.109970_bb0050","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00109-018-01739-9","article-title":"Pathological role of apoptosis signal-regulating kinase 1 in human diseases and its potential as a therapeutic target for cognitive disorders","volume":"97","author":"Cheon","year":"2019","journal-title":"J. Mol. Med. Berl. Ger."},{"key":"10.1016\/j.bioorg.2026.109970_bb0055","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2103812119","article-title":"ASK1 signaling regulates phase-specific glial interactions during neuroinflammation","volume":"119","author":"Guo","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bioorg.2026.109970_bb0060","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3233\/JAD-170645","article-title":"Role of ASK1\/p38 Cascade in a mouse model of Alzheimer's disease and brain aging","volume":"61","author":"Hasegawa","year":"2018","journal-title":"J. Alzheimers Dis. JAD"},{"key":"10.1016\/j.bioorg.2026.109970_bb0065","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3233\/JAD-215687","article-title":"Oxidative stress kinase activation and impaired insulin receptor Signaling precede overt Alzheimer's disease neuropathology","volume":"90","author":"Shen","year":"2022","journal-title":"J. Alzheimers Dis. JAD"},{"key":"10.1016\/j.bioorg.2026.109970_bb0070","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.expneurol.2008.10.008","article-title":"Implication of the JNK pathway in a rat model of Huntington's disease","volume":"215","author":"Perrin","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bioorg.2026.109970_bb0075","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00109-007-0299-6","article-title":"ASK1 and MAP2K6 as modifiers of age at onset in Huntington's disease","volume":"86","author":"Arning","year":"2008","journal-title":"J. Mol. Med. Berl. Ger."},{"key":"10.1016\/j.bioorg.2026.109970_bb0080","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/neup.12978","article-title":"ASK1 activation in glial cells in post-mortem multiple sclerosis tissue","volume":"45","author":"Seki","year":"2025","journal-title":"Neuropathol. Off. J. Jpn. Soc. Neuropathol."},{"key":"10.1016\/j.bioorg.2026.109970_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115889","article-title":"Small-molecule inhibitors targeting apoptosis signal-regulated kinase 1","volume":"262","author":"Wang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109970_bb0090","doi-asserted-by":"crossref","first-page":"15402","DOI":"10.1021\/acs.jmedchem.1c01458","article-title":"Discovery of potent, selective, and brain-penetrant apoptosis signal-regulating kinase 1 (ASK1) inhibitors that modulate brain inflammation in vivo","volume":"64","author":"Jones","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109970_bb0095","doi-asserted-by":"crossref","first-page":"2414382","DOI":"10.1080\/14756366.2024.2414382","article-title":"Synthesis and biological evaluation of quinoxaline derivatives as ASK1 inhibitors","volume":"39","author":"Han","year":"2024","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109970_bb0100","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/bs.pmch.2020.02.001","article-title":"Discovery and development of ASK1 inhibitors","volume":"59","author":"Brys","year":"2020","journal-title":"Prog. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109970_bb0105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000369152","article-title":"Design of a phase 2 clinical trial of an ASK1 inhibitor, GS-4997, in patients with diabetic kidney disease","volume":"129","author":"Lin","year":"2015","journal-title":"Nephron"},{"key":"10.1016\/j.bioorg.2026.109970_bb0110","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/hep.29514","article-title":"GS-US-384-1497 investigators, the ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: a randomized, phase 2 trial","volume":"67","author":"Loomba","year":"2018","journal-title":"Hepatol. Baltim. Md"},{"key":"10.1016\/j.bioorg.2026.109970_bb0115","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jhep.2020.02.027","article-title":"STELLAR-3, STELLAR-4 investigators, Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: results from randomized phase III STELLAR trials","volume":"73","author":"Harrison","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bioorg.2026.109970_bb0120","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1681\/ASN.0000000000000444","article-title":"Selonsertib in patients with diabetic kidney disease: a phase 2b randomized active run-in clinical trial","volume":"35","author":"Heerspink","year":"2024","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"10.1016\/j.bioorg.2026.109970_bb0125","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.canlet.2018.10.007","article-title":"Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells","volume":"440\u2013441","author":"Ji","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioorg.2026.109970_bb0130","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s40262-020-00878-y","article-title":"Pharmacokinetics, safety, and tolerability of Selonsertib, an apoptosis signal-regulating kinase 1 (ASK1) inhibitor, following first-in-human single and multiple ascending doses in healthy subjects","volume":"59","author":"Nelson","year":"2020","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.bioorg.2026.109970_bb0135","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/hep.31622","article-title":"For the ATLAS investigators, combination therapies including Cilofexor and Firsocostat for bridging fibrosis and cirrhosis attributable to NASH","volume":"73","author":"Loomba","year":"2021","journal-title":"Hepatol. Baltim. Md"},{"key":"10.1016\/j.bioorg.2026.109970_bb0140","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1007\/s11064-022-03777-9","article-title":"Anti-neuroinflammatory effects and brain pharmacokinetic properties of Selonsertib, an apoptosis signal-regulating kinase 1 inhibitor, in mice","volume":"47","author":"Lee","year":"2022","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bioorg.2026.109970_bb0145","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/emmm.201000103","article-title":"Regulation of the severity of neuroinflammation and demyelination by TLR-ASK1-p38 pathway","volume":"2","author":"Guo","year":"2010","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bioorg.2026.109970_bb0150","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrd2290","article-title":"Molecular imaging in drug development","volume":"7","author":"Willmann","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2026.109970_bb0155","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1021\/cr0782426","article-title":"Molecular imaging with PET","volume":"108","author":"Ametamey","year":"2008","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2026.109970_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2026.130628","article-title":"The design, synthesis and evaluation of [18F]ASK1-IN-6 as the first Fuorine-18 positron emission tomography radiotracer for ASK1 neuroimaging","volume":"137","author":"Huang","year":"2026","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.109970_bb0165","doi-asserted-by":"crossref","first-page":"12932","DOI":"10.1039\/C9CC06734E","article-title":"Positron emission tomography probes targeting bromodomain and extra-terminal (BET) domains to enable in vivo neuroepigenetic imaging","volume":"55","author":"Bai","year":"2019","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bioorg.2026.109970_bb0170","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S2213-2600(21)00032-1","article-title":"ARROW study group, Selonsertib in adults with pulmonary arterial hypertension (ARROW): a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"10","author":"Rosenkranz","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.bioorg.2026.109970_bb0175","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1021\/acsmedchemlett.9b00611","article-title":"Discovery of CNS-penetrant apoptosis signal-regulating kinase 1 (ASK1) inhibitors","volume":"11","author":"Xin","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.109970_bb0180","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.3390\/antiox10091363","article-title":"p47phox-dependent oxidant signalling through ASK1, MKK3\/6 and MAPKs in angiotensin II-induced cardiac hypertrophy and apoptosis","volume":"10","author":"Liu","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.bioorg.2026.109970_bb0185","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1002\/hep4.1956","article-title":"Phosphoproteomics identifies pathways underlying the role of receptor-interaction protein kinase 3 in alcohol-associated liver disease and uncovers apoptosis signal-regulating kinase 1 as a target","volume":"6","author":"Singh","year":"2022","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.bioorg.2026.109970_bb0190","article-title":"Apigenin ameliorates non-eosinophilic inflammation, dysregulated immune homeostasis and mitochondria-mediated airway epithelial cell apoptosis in chronic obese asthma via the ROS-ASK1-MAPK pathway","volume":"111","author":"Yu","year":"2023","journal-title":"Phytomedicine Int. J. Phytother. Phytopharm."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826005067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826005067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T15:15:27Z","timestamp":1783178127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826005067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":38,"alternative-id":["S0045206826005067"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109970","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The design, synthesis and evaluation of the first carbon-11 positron emission tomography radiotracer for ASK1 imaging","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109970","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109970"}}